Table 1.
Cell Source | Derivation | In vitro Expansion | Reprogramming Efficiency (4Factor) | Reprogramming Speed | Reprogramming Factors | References |
---|---|---|---|---|---|---|
Skin Fibroblasts | Skin Biopsy | Yes | ~0.01% (Adult cells) | >21 days | OSKM, OSK, OSNL | 1–7 |
Neural Stem Cells | NA | Yes | 0.004% (1Factor, Fetal cells) | >7–8 weeks (1Factor) | OK, O | 9 |
Keratinocytes | Skin Biopsy | Yes | ~1% (neonatal and juvenile cells) | >10 days | OSKM, OSK | 10 |
CD34 Blood Cells | Peripheral blood undergo G-CSF stimulation | No | ~0.01–0.02% (Adult cells) | >14 days | OSKM | 11 |
Adipose Stem Cells | Lipoaspiration | No | ~ 0.2% (Adult cells) | >13–14 days | OSKM | 15 |
Melanocytes | Skin Biopsy | Yes | ~0.05% (not known) | >10 days | OSKM, OKM | 14 |
Cord Blood Cells | Collected at birth from cord blood | No | ~ 0.01% (neonatal cells) | >12–15 days | OSKM, OSNL, OSK, OS | 17, 18 |
O: Oct4, S: Sox2, K: Klf4, M: c-MYC, N: Nanog, L: Lin-28, NA: Not Applicable